Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorvardur R Halfdanarson

Showing results (161-170 of 213) with videos related to

Pageof 22
Sort By:
Cancer|June 25, 2025
Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasmsDavid G Su, Leanne M Brown, Varun V Bansal, et al.
AJR. American Journal of Roentgenology|October 21, 2020
Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of SurvivalAnanya Panda, Ishan Garg, Mark J Truty, et al.
JCO Oncology Practice|June 4, 2021
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19Joshua C Pritchett, Bijan J Borah, Aakash P Desai, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 11, 2025
Long-term outcome of cytoreductive hepatectomy in metastatic neuroendocrine neoplasia G3: A single center retrospective analysisMarkus Ammann, Hallbera Gudmundsdottir, Stella K Adjei Antwi, et al.
Clinical and Translational Radiation Oncology|March 18, 2021
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experienceKrishan R Jethwa, Courtney N Day, Harigopal Sandhyavenu, et al.
The Oncologist|August 3, 2021
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective ReviewDavid L Chan, Emily K Bergsland, Jennifer A Chan, et al.
Endocrine-Related Cancer|May 15, 2023
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasmsJennifer R Eads, Thorvardur R Halfdanarson, Tim Asmis, et al.
Pancreas|September 29, 2020
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine TumorsJennifer R Eads, Diane Reidy-Lagunes, Heloisa P Soares, et al.
Annals of Surgery|April 5, 2019
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic CancerMark J Truty, Michael L Kendrick, David M Nagorney, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 9, 2023
Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTsSovanlal Mukherjee, Panagiotis Korfiatis, Hala Khasawneh, et al.
Pageof 22

Showing results (161-170 of 213) with videos related to

Sort By:
Pageof 22
Cancer|June 25, 2025
Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasmsDavid G Su, Leanne M Brown, Varun V Bansal, et al.
AJR. American Journal of Roentgenology|October 21, 2020
Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of SurvivalAnanya Panda, Ishan Garg, Mark J Truty, et al.
JCO Oncology Practice|June 4, 2021
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19Joshua C Pritchett, Bijan J Borah, Aakash P Desai, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 11, 2025
Long-term outcome of cytoreductive hepatectomy in metastatic neuroendocrine neoplasia G3: A single center retrospective analysisMarkus Ammann, Hallbera Gudmundsdottir, Stella K Adjei Antwi, et al.
Clinical and Translational Radiation Oncology|March 18, 2021
Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experienceKrishan R Jethwa, Courtney N Day, Harigopal Sandhyavenu, et al.
The Oncologist|August 3, 2021
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective ReviewDavid L Chan, Emily K Bergsland, Jennifer A Chan, et al.
Endocrine-Related Cancer|May 15, 2023
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasmsJennifer R Eads, Thorvardur R Halfdanarson, Tim Asmis, et al.
Pancreas|September 29, 2020
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine TumorsJennifer R Eads, Diane Reidy-Lagunes, Heloisa P Soares, et al.
Annals of Surgery|April 5, 2019
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic CancerMark J Truty, Michael L Kendrick, David M Nagorney, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 9, 2023
Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTsSovanlal Mukherjee, Panagiotis Korfiatis, Hala Khasawneh, et al.
Pageof 22